NCT06545435

Brief Summary

This study aims to develop and cross-validate novel bioelectrical impedance analysis (BIA) equations for predicting appendicular soft tissue masses, specifically fat mass (FM) and appendicular lean mass (ALM), in a sample of Caucasian adult subjects affected by obesity. The research will compare these new BIA equations with three established BIA-derived prediction models and validate them using dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI) data. This study utilizes existing datasets to enhance the accuracy and applicability of BIA in assessing body composition and supports the development of standardized algorithms for converting raw BIA data across different devices and populations.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Longer than P75 for all trials

Geographic Reach
6 countries

9 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2021

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

4.1 years

First QC Date

August 5, 2024

Last Update Submit

August 22, 2024

Conditions

Keywords

Appendicular Lean MassFat MassBody CompositionBio-Impedance Analysis

Outcome Measures

Primary Outcomes (1)

  • Development and Cross-Validation of BIA Equations for Appendicular Soft Tissue Masses

    This primary outcome measures the accuracy and cross-validation of newly developed bioelectrical impedance analysis (BIA) equations in predicting appendicular soft tissue masses, including fat mass (FM) and appendicular lean mass (ALM), in Caucasian adults with obesity. The aim is to validate these equations against dual-energy X-ray absorptiometry (DXA) measurements.

    Baseline

Secondary Outcomes (4)

  • Comparison of New BIA Equations with Existing Models

    Baseline

  • Algorithm Development for Conversion Between BIA Devices

    Baseline

  • Cross-Validation of New BIA Equations with Different DXA Systems

    Baseline

  • Validation of BIA Equations Using Magnetic Resonance Imaging (MRI)

    Baseline

Study Arms (2)

Obese Adults Cohort

This cohort includes Caucasian adult subjects with obesity (BMI ≥ 30 kg/m²). Participants have undergone baseline assessments using both Dual X-ray Absorptiometry (DXA) and Bioelectrical Impedance Analysis (BIA).

MRI Validation Subset

A subset of participants from the Obese Adults Cohort selected for additional validation using Magnetic Resonance Imaging (MRI) to assess muscle size and architecture.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cohort of Caucasian adult subjects with obesity, specifically those who have undergone baseline body composition assessments using Dual X-ray Absorptiometry (DXA) and Bioelectrical Impedance Analysis (BIA). Participants are selected from existing datasets, including individuals with a Body Mass Index (BMI) of 30 kg/m² or higher. Eligible participants are aged 18 years and older and have provided informed consent for their data to be used in research. The population excludes those with conditions that may significantly affect body composition.

You may qualify if:

  • Adults with obesity (BMI ≥ 30 kg/m²)
  • Age 18 years and older
  • Available baseline DXA and BIA measurements
  • Provided informed consent for data use

You may not qualify if:

  • any chronic disease or medication that can significantly affect body composition \[eg. malignant diseases in the last 5 years, organ failure, acute inflammation (C-reactive protein\>10 mg/L) autoimmune diseases, neurological diseases, syndromic obesity\]
  • cognitive impairment (Mini-Mental State Examination \<25)
  • subjects that are considered physically active (athletes or very active subjects i.e., performing at least 150 minutes of moderate to vigorous physical activity per week)
  • alcohol intake \>140g/wk for Males and 70g/wk for Females
  • participation in a weight-reducing program (last 3 months)
  • impossibility to perform DXA exam
  • pregnancy and breast-feeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Pennington Biomedical Research Center, Louisiana State University

Baton Rouge, Louisiana, 70808, United States

RECRUITING

Division of Geriatric Medicine, School of Medicine, and Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27514, United States

RECRUITING

Curtin University, School of Population Health

Perth, 6102, Australia

RECRUITING

Federal University of Pelotas

Pelotas, Rio Grande do Sul, 96010-610, Brazil

RECRUITING

University of Alberta, Department of Agricultural, Food and Nutritional Science

Edmonton, Alberta, T6G 2P5, Canada

RECRUITING

University of Cagliari, Department of Life and Environmental Sciences

Cagliari, 09042, Italy

RECRUITING

Sapienza, University of Rome

Roma, Italy

RECRUITING

Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy

Trieste, Italy

RECRUITING

Universidade de Lisboa, Exercise and Health Laboratory, CIPER, Faculdade de Motricidade Humana

Lisbon, 1495-751, Portugal

RECRUITING

Related Publications (21)

  • Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998 Apr 15;147(8):755-63. doi: 10.1093/oxfordjournals.aje.a009520.

    PMID: 9554417BACKGROUND
  • Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, Dahlqvist Leinhard O. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018 Jun;66(5):1-9. doi: 10.1136/jim-2018-000722. Epub 2018 Mar 25.

    PMID: 29581385BACKGROUND
  • Gortan Cappellari G, Guillet C, Poggiogalle E, Ballesteros Pomar MD, Batsis JA, Boirie Y, Breton I, Frara S, Genton L, Gepner Y, Gonzalez MC, Heymsfield SB, Kiesswetter E, Laviano A, Prado CM, Santini F, Serlie MJ, Siervo M, Villareal DT, Volkert D, Voortman T, Weijs PJ, Zamboni M, Bischoff SC, Busetto L, Cederholm T, Barazzoni R, Donini LM; SOGLI Expert Panel. Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022. Clin Nutr. 2023 May;42(5):687-699. doi: 10.1016/j.clnu.2023.02.018. Epub 2023 Feb 24.

    PMID: 36947988BACKGROUND
  • Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, Frara S, Fruhbeck G, Genton L, Gepner Y, Giustina A, Gonzalez MC, Han HS, Heymsfield SB, Higashiguchi T, Laviano A, Lenzi A, Nyulasi I, Parrinello E, Poggiogalle E, Prado CM, Salvador J, Rolland Y, Santini F, Serlie MJ, Shi H, Sieber CC, Siervo M, Vettor R, Villareal DT, Volkert D, Yu J, Zamboni M, Barazzoni R. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr. 2022 Apr;41(4):990-1000. doi: 10.1016/j.clnu.2021.11.014. Epub 2022 Feb 22.

    PMID: 35227529BACKGROUND
  • Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar;49(2):M85-94. doi: 10.1093/geronj/49.2.m85.

    PMID: 8126356BACKGROUND
  • Hamilton-James K, Collet TH, Pichard C, Genton L, Dupertuis YM. Precision and accuracy of bioelectrical impedance analysis devices in supine versus standing position with or without retractable handle in Caucasian subjects. Clin Nutr ESPEN. 2021 Oct;45:267-274. doi: 10.1016/j.clnesp.2021.08.010. Epub 2021 Sep 6.

    PMID: 34620328BACKGROUND
  • Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002 May;50(5):889-96. doi: 10.1046/j.1532-5415.2002.50216.x.

    PMID: 12028177BACKGROUND
  • Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C. Single prediction equation for bioelectrical impedance analysis in adults aged 20--94 years. Nutrition. 2001 Mar;17(3):248-53. doi: 10.1016/s0899-9007(00)00553-0.

    PMID: 11312069BACKGROUND
  • Kyle UG, Genton L, Hans D, Pichard C. Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass (ASMM). Clin Nutr. 2003 Dec;22(6):537-43. doi: 10.1016/s0261-5614(03)00048-7.

    PMID: 14613755BACKGROUND
  • Lohman, T.G., Roche, A.F. and Martorell, R. (1988) Anthropometric standardization reference manual. Human Kinetics Books, Chicago.

    BACKGROUND
  • Poggiogalle E, Mendes I, Ong B, Prado CM, Mocciaro G, Mazidi M, Lubrano C, Lenzi A, Donini LM, Siervo M. Sarcopenic obesity and insulin resistance: Application of novel body composition models. Nutrition. 2020 Jul-Aug;75-76:110765. doi: 10.1016/j.nut.2020.110765. Epub 2020 Feb 13.

    PMID: 32279031BACKGROUND
  • Prado CM, Siervo M, Mire E, Heymsfield SB, Stephan BC, Broyles S, Smith SR, Wells JC, Katzmarzyk PT. A population-based approach to define body-composition phenotypes. Am J Clin Nutr. 2014 Jun;99(6):1369-77. doi: 10.3945/ajcn.113.078576. Epub 2014 Apr 23.

    PMID: 24760978BACKGROUND
  • Salmon-Gomez L, Catalan V, Fruhbeck G, Gomez-Ambrosi J. Relevance of body composition in phenotyping the obesities. Rev Endocr Metab Disord. 2023 Oct;24(5):809-823. doi: 10.1007/s11154-023-09796-3. Epub 2023 Mar 17.

    PMID: 36928809BACKGROUND
  • Scafoglieri A, Clarys JP, Bauer JM, Verlaan S, Van Malderen L, Vantieghem S, Cederholm T, Sieber CC, Mets T, Bautmans I; Provide Study Group. Predicting appendicular lean and fat mass with bioelectrical impedance analysis in older adults with physical function decline - The PROVIDE study. Clin Nutr. 2017 Jun;36(3):869-875. doi: 10.1016/j.clnu.2016.04.026. Epub 2016 Apr 28.

    PMID: 27178302BACKGROUND
  • Sergi G, De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, Bano G, Coin A, Manzato E, Perissinotto E. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2015 Aug;34(4):667-73. doi: 10.1016/j.clnu.2014.07.010. Epub 2014 Jul 24.

    PMID: 25103151BACKGROUND
  • Shepherd JA, Fan B, Lu Y, Wu XP, Wacker WK, Ergun DL, Levine MA. A multinational study to develop universal standardization of whole-body bone density and composition using GE Healthcare Lunar and Hologic DXA systems. J Bone Miner Res. 2012 Oct;27(10):2208-16. doi: 10.1002/jbmr.1654.

    PMID: 22623101BACKGROUND
  • Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. Body composition by DXA. Bone. 2017 Nov;104:101-105. doi: 10.1016/j.bone.2017.06.010. Epub 2017 Jun 16.

    PMID: 28625918BACKGROUND
  • Toombs RJ, Ducher G, Shepherd JA, De Souza MJ. The impact of recent technological advances on the trueness and precision of DXA to assess body composition. Obesity (Silver Spring). 2012 Jan;20(1):30-9. doi: 10.1038/oby.2011.211. Epub 2011 Jul 14.

    PMID: 21760631BACKGROUND
  • Vendrami C, Gatineau G, Gonzalez Rodriguez E, Lamy O, Hans D, Shevroja E. Standardization of body composition parameters between GE Lunar iDXA and Hologic Horizon A and their clinical impact. JBMR Plus. 2024 Jul 10;8(9):ziae088. doi: 10.1093/jbmrpl/ziae088. eCollection 2024 Sep.

    PMID: 39108357BACKGROUND
  • Ward LC. Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation. Eur J Clin Nutr. 2019 Feb;73(2):194-199. doi: 10.1038/s41430-018-0335-3. Epub 2018 Oct 8.

    PMID: 30297760BACKGROUND
  • Zambone MA, Liberman S, Garcia MLB. Anthropometry, bioimpedance and densitometry: Comparative methods for lean mass body analysis in elderly outpatients from a tertiary hospital. Exp Gerontol. 2020 Sep;138:111020. doi: 10.1016/j.exger.2020.111020. Epub 2020 Jul 9.

    PMID: 32653450BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Eleonora Poggiogalle, Md, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

August 5, 2024

First Posted

August 9, 2024

Study Start

May 13, 2021

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

August 26, 2024

Record last verified: 2024-08

Locations